Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Ajanta Pharma Ltd

NSE: AJANTPHARM · BSE: 532331 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹3,570.00
Market cap
₹44,610 Cr
Revenue (annual)
₹5,453 Cr
Net profit (annual)
₹1,056 Cr
P/E (TTM)
39.3×Sector 47.4×
Promoter holding
63.48%-2.77% QoQ
FII holding
7.68%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:13 IST NSE
Board Meeting Outcome

Ajanta Pharma Board Meeting Outcome

Ajanta Pharma Limited's board met on May 5, 2026, and approved the re-appointment of Aneja Assurance Pvt. Ltd as Internal Auditor, RA & Co as Cost Auditors, and M/s. R S Sanghai & Associates as Tax Auditors. All appointments are for a 12-month term.

Execution
12 months
15:42 IST BSE
Board Meeting Outcome

Ajanta Pharma Board Meeting Outcome

Ajanta Pharma Ltd's Board approved the re-appointment of Aneja Assurance Pvt. Ltd. as Internal Auditors, RA & Co. as Cost Auditors, and R S Sanghai & Associates as Tax Auditors for FY 2026-27. The appointments were made during the Board meeting held on May 5, 2026.

Execution
FY 2026-27
15:59 IST BSE
Board Meeting Outcome

Ajanta Pharma Board Meeting Outcome

Ajanta Pharma Ltd has scheduled a Board Meeting on May 5, 2026. The board will primarily consider and approve the audited standalone and consolidated financial results and statements for the quarter and year ended March 31, 2026.